Company Information
USD
32.48
- (0.03%)
NASDAQ:CBAY, CYMABAY THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 21 March 2024 GMT-4
CymaBay Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases with high unmet medical need. Its product in pipeline includes two clinical stage product candidates: seladelpar (a PPARd agonist) and MBX-2982 (a GPR119 agonist).
Address
7601 Dumbarton Circle
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Harish Shantharam
CFO/Chief Accounting Officer
Ms. Klara A. Dickinson
Other Executive Officer
Mr. Kurt von Emster, C.F.A.
Director
Mr. Thomas G. Wiggans
Director
Ms. Caroline M. Loewy
Director
Mr. Paul T. Quinlan PhD
Chief Compliance Officer/General Counsel/Secretary
Mr. Sujal Shah
CEO/Director/President
Dr. Charles A. McWherter, PhD.
Chief Scientific Officer/President, Divisional
Dr. Eric Lefebvre, M.D.
Director
Dr. Robert J. Wills, PhD
Chairman of the Board/Director
Ms. Janet Dorling
Director
Ownership
Institution Holdings
venBio Select Advisor LLC
11,111,111 (9.680%)
BlackRock Inc
9,610,239 (8.372%)
RA Capital Management, LLC
6,940,000 (6.046%)
RA Capital Management, LP
6,940,000 (6.046%)
Vanguard Group Inc
6,306,149 (5.494%)
HHG PLC
6,103,797 (5.318%)
BlackRock Fund Advisors
5,382,982 (4.690%)
T. Rowe Price Associates, Inc.
4,465,161 (3.890%)
Fidelity Management & Research Company LLC
4,233,971 (3.689%)
Perceptive Advisors LLC
4,024,400 (3.506%)
Funds Holdings
Vanguard US Total Market Shares ETF
3,534,074 (3.079%)
Vanguard Total Stock Market Index Fund
3,534,074 (3.079%)
iShares Russell 2000 ETF
2,760,533 (2.405%)
Janus Henderson Global Life Science
1,613,473 (1.406%)
Janus Henderson Global Life Sciences Fd
1,613,473 (1.406%)
Vanguard Institutional Extnd Mkt Idx Tr
1,611,693 (1.404%)
Franklin Biotechnology Discovery Fund
1,554,293 (1.354%)
Alger Small Cap Focus Fund
1,479,686 (1.289%)
Alger Small Cap Focus
1,479,686 (1.289%)
Janus Global Life Science Fund
1,217,523 (1.061%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
